Welcome to plenary session.

I'm Dr. Vinay Prasad. I'm an associate professor at the University of California, San Francisco.

My interests are medicine, hematology, oncology, and health policy, and that's what you're going to get on this podcast.

This week, we got a great episode in store for you.

We've got an interview, and I think you're going to really like this.

But first, a plug.

If you like this podcast, check out the new website, www.

www. plenary session podcast.com.

We've got show notes, we've got trial summaries, we've got everything you could want on the website.

Follow us on Twitter at plenary underscore session.

Write a review for us on the iTunes store.

And become a supporter for this podcast on Patreon.

Patreon backers get access to the slides for presentations I give on plenary session. You also get a few bonus lectures.

And with that, let's start the show. All right, I think we're rolling. I'm back in plenary session.

Join via Zoom for a real treat. I'm speaking with Martin Kuldorf.

Professor Kuldorf is a professor at the Harvard Medical School. He specializes in surveillance for infectious disease and other problems. Dr. Kulzdorf, it's a pleasure. It's a pleasure to speak with you this morning.

It's a great pleasure to be here with you. Thank you so much for inviting me. Oh, well, it's a pleasure to speak with you this morning. It's a great pleasure to be here with you.

Thank you so much for inviting me.

Oh, well, it's my pleasure.

I mean, there's so many things to talk about with you.

I mean, obviously, there are issues of SARS-Cove 2 and COVID policy,

which I'm going to be very interested to have you kind of articulate your point of view on. And then there are the meta issues, I think, which is that, you know,

...